Key result
IV amiodarone effectively controls acute tachyarrhythmias with minimal hemodynamic impairment.
Why the study?
The clinical applications, electropharmacology, side effects, and hemodynamic profile of intravenous amiodarone in managing cardiac arrhythmias required comprehensive review.
Is intravenous amiodarone effective and safe for the short-term treatment of life-threatening or hemodynamically unstable cardiac arrhythmias?
Population
Patients with supraventricular and ventricular arrhythmias including those related to myocardial infarction
Comparison
Intravenous amiodarone versus other antiarrhythmic agents or oral amiodarone
Design
Review of clinical trials, in vivo studies, and pharmacologic reports from 1985 to 1996
Authors
Loading...
Supports IV amiodarone for unstable arrhythmias; confirms efficacy and safety in Level 1 synthesis.
Is intravenous amiodarone effective and safe for the short-term treatment of life-threatening or hemodynamically unstable cardiac arrhythmias?
Intravenous amiodarone is a promising, effective, and hemodynamically well-tolerated option for the short-term management of unstable and refractory cardiac arrhythmias.
Aseem D. Desai (1997) conducted a review in Cardiac arrhythmias. Intravenous amiodarone was evaluated. Intravenous amiodarone is an effective short-term treatment for unstable supraventricular and ventricular arrhythmias, offering a favorable hemodynamic profile and minimal short-term side effects.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: